Corrigendum to "Activation of Galanin receptor 1 with M617 attenuates neuronal apoptosis via ERK/GSK-3β/TIP60 pathway after subarachnoid hemorrhage in Rats" [Neurotherapeutics 18 (3) (2021) 1905-1921].

IF 5.6 2区医学 Q1 CLINICAL NEUROLOGY

Neurotherapeutics Pub Date : 2024-10-01 Epub Date: 2024-10-17 DOI:10.1016/j.neurot.2024.e00468

Hui Shi, Yuanjian Fang, Lei Huang, Ling Gao, Cameron Lenahan, Takeshi Okada, Zachary D Travis, Shucai Xie, Hong Tang, Qin Lu, Rui Liu, Jiping Tang, Yuan Cheng, John H Zhang

引用次数: 0

查看原文本刊更多论文

用M617激活Galanin受体1，通过ERK/GSK-3β/TIP60途径减轻大鼠蛛网膜下腔出血后神经细胞凋亡》的更正 [Neurotherapeutics 18 (3) (2021) 1905-1921]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurotherapeutics 医学-神经科学

CiteScore

11.00

自引率

3.50%

发文量

154

审稿时长

6-12 weeks

期刊介绍： Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities. The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field. Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.